Bictegravir Voriconazole 83

Clinical Bottom Line
Minimal data to guide interaction: weigh risks and benefits of using this combination
Drug 1
Drug 1 dose
75mg single dose
Drug 1 effect

Cmax increased 9%, AUC increased 61%

Drug 2
Drug 2 dose
300 mg BID (fasted state)
Drug 2 effect

Not reported

Clinical Effects

Potentially increased bictegravir adverse effects

Management

Consider using alternative agents; if coadministering, monitor for bictegravir adverse effects

Import ID
83